- Home
- SRPT vs HUMAW Comparison
SRPT vs HUMAW Comparison
Compare SRPT & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- HUMAW
- Stock Information
- Founded
- SRPT 1980
- HUMAW 2004
- Country
- SRPT United States
- HUMAW United States
- Employees
- SRPT N/A
- HUMAW N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- SRPT Health Care
- HUMAW Health Care
- Exchange
- SRPT Nasdaq
- HUMAW Nasdaq
- Market Cap
- SRPT N/A
- HUMAW N/A
- IPO Year
- SRPT 1997
- HUMAW N/A
- Fundamental
- Price
- SRPT $109.46
- HUMAW $1.22
- Analyst Decision
- SRPT Buy
- HUMAW
- Analyst Count
- SRPT 22
- HUMAW 0
- Target Price
- SRPT $174.64
- HUMAW N/A
- AVG Volume (30 Days)
- SRPT 776.4K
- HUMAW 14.2K
- Earning Date
- SRPT 02-26-2025
- HUMAW 03-21-2025
- Dividend Yield
- SRPT N/A
- HUMAW N/A
- EPS Growth
- SRPT N/A
- HUMAW N/A
- EPS
- SRPT 1.22
- HUMAW N/A
- Revenue
- SRPT $1,640,348,000.00
- HUMAW N/A
- Revenue This Year
- SRPT $53.06
- HUMAW N/A
- Revenue Next Year
- SRPT $68.79
- HUMAW N/A
- P/E Ratio
- SRPT $89.23
- HUMAW N/A
- Revenue Growth
- SRPT 48.45
- HUMAW N/A
- 52 Week Low
- SRPT $102.16
- HUMAW $1.20
- 52 Week High
- SRPT $173.25
- HUMAW $1.25
- Technical
- Relative Strength Index (RSI)
- SRPT 36.11
- HUMAW N/A
- Support Level
- SRPT $109.52
- HUMAW N/A
- Resistance Level
- SRPT $114.41
- HUMAW N/A
- Average True Range (ATR)
- SRPT 3.32
- HUMAW 0.00
- MACD
- SRPT -0.45
- HUMAW 0.00
- Stochastic Oscillator
- SRPT 13.97
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.